Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EPIZYME, INC.

(EPZM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on EPIZYME, INC.
08/10EPIZYME : Morgan Stanley Lowers Epizyme to Underweight From Equal-Weight, Price Target to ..
MT
08/10EPIZYME : HC Wainwright Adjusts Epizyme's Price Target to $15 From $36, Maintains Buy Rati..
MT
08/10EPIZYME : Wedbush Cuts Epizyme's Price Target to $12 From $26, Citing 'Lower-Than-Expected..
MT
05/07EPIZYME : Morgan Stanley Adjusts Epizyme's Price Target to $10 From $11, Keeps Equal-Weigh..
MT
05/07EPIZYME : SVB Leerink Upgrades Epizyme to Outperform From Market Perform, Adjusts Price Ta..
MT
05/06EPIZYME : Wedbush Adjusts Epizyme's Price Target to $26 From $27, Maintains Outperform Rat..
MT
04/19EPIZYME : Morgan Stanley Adjusts Price Target on Epizyme to $11 From $14, Maintains Equal-..
MT
03/31EPIZYME : Credit Suisse Starts Epizyme at Outperform with $13 Price Target
MT
02/25EPIZYME : Morgan Stanley Downgrades Epizyme to Equal-Weight From Overweight; Price Target ..
MT
2020EPIZYME : Jefferies Downgrades Epizyme to Hold From Buy, Adjusts Price Target to $14 From ..
MT
2020EPIZYME : Barclays Adjusts Epizyme's Price Target to $18 From $33, Maintains Overweight Ra..
MT
2020EPIZYME : Morgan Stanley Adjusts Epizyme PT to $27 From $29, Maintains Overweight Rating
MT
Upcoming event on EPIZYME, INC.
11/03/21